Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND4 pseudogene 22 (MTND4P22) is a nuclear pseudogene derived from mitochondrial DNA and ancestrally related to the MT-ND4 gene, which encodes a core subunit of complex I in the mitochondrial electron transport chain. Unlike the functional mitochondrial MT-ND4 gene, which is involved in ATP production and implicated in diseases such as Leber hereditary optic neuropathy, pseudogenes such as MTND4P22 do not produce functional proteins and are not considered molecular targets for drugs, therapeutic intervention, or disease monitoring[7]. As such, MTND4P22 has no direct biological or clinical relevance, is not a target of any drugs, and does not have associated disease roles or biomarkers. Key clarification: MTND4P22 is not the same as the functional MT-ND4 gene or NADH dehydrogenase 4 protein (ND4), which is a critical component of mitochondrial electron transport and involved in several diseases[1][5][6]. MTND4P22 is nonfunctional and considered only as a genomic relic, with no known role in health or disease[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND4 pseudogene 22 (MTND4P22).